Revelation Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.81 | -$1.81 | -$1.81 |
| Q2 2024 | 1 | -$2.84 | -$2.84 | -$2.84 |
| Q3 2024 | 2 | -$0.95 | -$0.43 | -$0.69 |
| Q1 2025 | 2 | -$0.85 | -$0.33 | -$0.59 |
| Q2 2025 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q3 2025 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q4 2025 | 1 | -$0.58 | -$0.58 | -$0.58 |
Revelation Biosciences, Inc. Earnings Date And Information
Revelation Biosciences, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.84 earnings per share for the quarter, topping analysts' consensus estimates of $-2.84 by $2. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Revelation Biosciences, Inc. has generated $-1 earnings per share over the last year ($-0.53 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Revelation Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Revelation Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$2.84 | -$0.84 | 2 | $0 | $0 |
| 08/09/2024 | Q2 2024 | -$1.81 | -$5.13 | -3.32 | $0 | $0 |
| 05/10/2024 | Q1 2024 | -$5.39 | -$2.46 | 2.93 | $0 | |
| 03/22/2024 | Q4 2023 | -$10.94 | -$8.33 | 2.61 | $37,574 | |
| 11/09/2023 | Q3 2023 | -$9.01 | -$12.52 | -3.51 | $0 | |
| 08/11/2023 | Q2 2023 | -$9.91 | -$7.47 | 2.44 | $0 | |
| 05/22/2023 | Q1 2023 | -$19.52 | $189.15 | 208.67 | $0 | |
| 03/30/2023 | Q4 2022 | -$52.55 | -$52.78 | -0.23 | $0 | |
| 11/10/2022 | Q3 2022 | -$94.50 | -$56.95 | 37.55 | $0 | |
| 08/15/2022 | Q2 2022 | -$147.00 | -$125.94 | 21.06 | $0 | |
| 05/13/2022 | Q1 2022 | -$4.90 | -$491.44 | -486.54 | $0 | |
| 04/15/2022 | Q4 2021 | -$486.32 | $0 | |||
| 10/29/2021 | Q3 2021 | -$351.38 | $0 | |||
| 08/23/2021 | Q2 2021 | -$285.03 | $0 | |||
| 06/22/2021 | Q1 2021 | -$301.52 | $0 | |||
| 03/31/2021 | Q4 2020 | -$334.06 | $0 | |||
| 11/16/2020 | Q3 2020 | -$0.10 | $0 | |||
| 06/29/2020 | Q2 2020 | -$18.83 | $0 |
Revelation Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Revelation Biosciences, Inc.'s earnings date?
Revelation Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
-
Did Revelation Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Revelation Biosciences, Inc. (:REVB) reported $-0.84 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.84 by $2.
-
How can I listen to Revelation Biosciences, Inc.'s earnings conference call?
The conference call for Revelation Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Revelation Biosciences, Inc.'s conference call transcript?
The conference call transcript for Revelation Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Revelation Biosciences, Inc. generate each year?
Revelation Biosciences, Inc. (:REVB) has a recorded net income of $0. Revelation Biosciences, Inc. has generated $-0.53 earnings per share over the last four quarters.
-
What is Revelation Biosciences, Inc.'s price-to-earnings ratio?
Revelation Biosciences, Inc. (:REVB) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.
